We place a high priority on providing more treatment options for patients, to give them a better chance against the disease than just the current standard of care. All our physicians in the Lymphoma Service are also research scientists who are actively engaged in laboratory research.
Some of our current work in lymphoma involves:
- The development of new drugs, such as drugs that block key enzymes in lymphoma cells.
- Finding new ways to use existing cancer drugs or therapies, including combinations of chemotherapies, targeted therapies and radiation.
- Searching for new targets or pathways to attack the cancer.
- Understanding how lymphomas grow and spread, so we can find ways to stop them.
- Identifying biomarkers to help us predict a patient’s response to a specific therapy.